Athyrium Capital Management, LP
- SEC CIK
- 0001728001
- Latest filing
- Nov 12, 2024
PBYI holding history
Puma Biotechnology, Inc. in every 13F filed by Athyrium Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PBYI overviewAll 13F holders of PBYIFull Q3 2024 holdings
- Shares (Q3 2024)
- 1,256,411
- Value
- $3.20M
- % of portfolio
- 36.9%
- Quarters held
- 11
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 1,256,411 | $3.20M | 36.9% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,256,411 | $4.10M | 12.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,256,411 | $6.66M | 9.1% | −535,703−29.9% | Reduced | Holders |
| Q4 2023 | 1,792,114 | $7.76M | 11.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,792,114 | $4.71M | 4.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,792,114 | $6.33M | 4.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,792,114 | $5.54M | 2.0% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,792,114 | $7.58M | 3.2% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,792,114 | $4.25M | 1.6% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,792,114 | $5.11M | 2.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,792,114 | $5.16M | 1.8% | +1,792,114 | New | Holders |